UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000008061
Receipt No. R000009498
Official scientific title of the study Domestic collaborative research of Genome-wide association study (GWAS) in predicting the therapeutic responce and adversed effect of new anticancer drugs for hepatocellular carcinoma.
Date of disclosure of the study information 2012/07/01
Last modified on 2018/12/04 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Domestic collaborative research of Genome-wide association study (GWAS) in predicting the therapeutic responce and adversed effect of new anticancer drugs for hepatocellular carcinoma.
Title of the study (Brief title) New anticancer drugs for hepatocellular carcinoma and GWAS
Region
Japan

Condition
Condition Hepatocellular carinoma
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1
To identify genetic factor associated with therapeutic responce and adversed effect of new anticancer drug for hepatocellular carcinoma by use of genome-wide association study (GWAS)
Basic objectives2 Others
Basic objectives -Others Relationship between genetic factor and therapeutic response / adversed effect to new anticancer drugs for the treatment of hepatocellular carcinoma
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Relationship between genetic factor and therapeutic response / adversed effect to new anticancer drugs for the treatment of hepatocellular carcinoma
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 New anticancer drugs for the treatment of hepatocellular carcinoma approved after April 2009
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with hepatocellular carcinoma who were treated by new anticancer drugs for the treatment of hepatocellular carcinoma approved after April 2009
Key exclusion criteria Patients whom the physicians in charge judge their enrollment inappropriate
Target sample size 300

Research contact person
Name of lead principal investigator Shuichi Kaneko
Organization Graduate School of Medical Sciences, Kanazawa University
Division name Disease Control and Homeostasis
Address 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, JAPAN
TEL 076-265-2233
Email s-kaneko@m-kanazawa.jp

Public contact
Name of contact person Shuichi Kaneko
Organization Graduate School of Medical Sciences, Kanazawa University
Division name Disease Control and Homeostasis
Address 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, JAPAN
TEL 076-265-2000
Homepage URL
Email s-kaneko@m-kanazawa.jp

Sponsor
Institute Disease Control and Homeostasis, Graduate School of Medical Sciences, Kanazawa University
Institute
Department

Funding Source
Organization Graduate School of Medical Sciences, Kanazawa University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 独立行政法人・国立国際医療肝炎センター(東京都),東京大学大学院医学系研究科・人類遺伝学教室(東京都),福井大学(福井県),愛媛大学(愛媛県),鳥取大学(鳥取県),千葉大学(千葉県),山口大学(山口県),大阪大学(大阪府),杏林大学(東京都),山形大学(山形県),昭和大学(東京都),兵庫医科大学(兵庫県),近畿大学(大阪府),岐阜大学(岐阜県),岡山大学(岡山県),久留米大学(福岡県),財団法人佐々木研究所附属杏雲堂病院(東京府),福井県済生会病院(福井県),埼玉医科大学(埼玉県),およびそれらの関連施設

Other administrative information
Date of disclosure of the study information
2012 Year 07 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2011 Year 11 Month 28 Day
Anticipated trial start date
2012 Year 07 Month 01 Day
Last follow-up date
2017 Year 03 Month 31 Day
Date of closure to data entry
2017 Year 03 Month 31 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 05 Month 30 Day
Last modified on
2018 Year 12 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009498